Contact Us to learn more about our healthcare solutions
610-994-2200

Insulin Management Advisor

The Insulin Management Advisor from Crossings Healthcare Solutions is available to help physicians manage complex inpatient hyperglycemic states effectively in a critical care setting. By leveraging the Cerner MPage platform, Crossings Healthcare was able to design a tool with embedded decision support that can improve patient outcomes and reduce variance across your organization.

Four advisors were created for Insulin Management:

  • Diabetic Ketoacidosis
  • Hyperglycemic Hyperosmolar State Advisor
  • Post Cardiac Surgery Insulin Advisor
  • Critical Care Insulin Advisor

Diabetic Ketoacidosis

This innovative tool has built-in decision support and is based on American Diabetic Association guidelines. It provides comprehensive, evidence-based treatment recommendations to clinicians. These include intravenous fluid management, acidosis and anion gap correction, glucose correction, electrolytes replacement and effective subcutaneous insulin transition once anion gap has been corrected.

Hyperglycemic Hyperosmolar State Advisor

This innovative tool has built-in decision support and is based on American Diabetic Association guidelines. It provides comprehensive evidence-based treatment recommendations to clinicians. These include intravenous fluid management, osmolality and anion gap correction, glucose correction, electrolytes replacement and effective subcutaneous insulin transition once serum osmolality and anion gap has been corrected.

Post Cardiac Surgery Insulin Advisor

This innovative tool has built-in decision support and is customized from clinical content from Portland Diabetes project. It provides comprehensive evidence-based intravenous and subcutaneous insulin treatment recommendations to clinicians. This tool effectively achieves glycemic control during cardiac surgery perioperative period.

Critical Care Insulin Advisor

This innovative tool has built-in decision support and is customized from clinical content from Portland Diabetes project. It provides comprehensive evidence based intravenous and subcutaneous insulin treatment recommendations to clinicians. This tool effectively achieves glycemic control during ICU stay